chr7-150947376-C-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 3P and 5B. PM1PP2BP4BS2

The NM_000238.4(KCNH2):​c.3104G>A​(p.Arg1035Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000417 in 1,536,496 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1035W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000043 ( 0 hom. )

Consequence

KCNH2
NM_000238.4 missense

Scores

2
6
11

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 0.736

Publications

1 publications found
Variant links:
Genes affected
KCNH2 (HGNC:6251): (potassium voltage-gated channel subfamily H member 2) This gene encodes a component of a voltage-activated potassium channel found in cardiac muscle, nerve cells, and microglia. Four copies of this protein interact with one copy of the KCNE2 protein to form a functional potassium channel. Mutations in this gene can cause long QT syndrome type 2 (LQT2). Transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, May 2022]
KCNH2 Gene-Disease associations (from GenCC):
  • long QT syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • long QT syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • short QT syndrome type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: MODERATE, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 29 uncertain in NM_000238.4
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 158 curated pathogenic missense variants (we use a threshold of 10). The gene has 38 curated benign missense variants. Gene score misZ: 3.3724 (above the threshold of 3.09). Trascript score misZ: 2.4846 (below the threshold of 3.09). GenCC associations: The gene is linked to long QT syndrome 2, Brugada syndrome, short QT syndrome type 1, short QT syndrome, long QT syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.37003055).
BS2
High AC in GnomAdExome4 at 60 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000238.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNH2
NM_000238.4
MANE Select
c.3104G>Ap.Arg1035Gln
missense
Exon 13 of 15NP_000229.1A0A090N8Q0
KCNH2
NM_001406753.1
c.2816G>Ap.Arg939Gln
missense
Exon 11 of 13NP_001393682.1Q12809-7
KCNH2
NM_172057.3
c.2084G>Ap.Arg695Gln
missense
Exon 9 of 11NP_742054.1Q12809-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNH2
ENST00000262186.10
TSL:1 MANE Select
c.3104G>Ap.Arg1035Gln
missense
Exon 13 of 15ENSP00000262186.5Q12809-1
KCNH2
ENST00000330883.9
TSL:1
c.2084G>Ap.Arg695Gln
missense
Exon 9 of 11ENSP00000328531.4Q12809-2
KCNH2
ENST00000713710.1
c.3038G>Ap.Arg1013Gln
missense
Exon 13 of 15ENSP00000519013.1A0AAQ5BGR0

Frequencies

GnomAD3 genomes
AF:
0.0000199
AC:
3
AN:
150540
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000243
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000295
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000552
AC:
8
AN:
144844
AF XY:
0.0000637
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000821
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000729
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000433
AC:
60
AN:
1385834
Hom.:
0
Cov.:
36
AF XY:
0.0000527
AC XY:
36
AN XY:
683606
show subpopulations
African (AFR)
AF:
0.0000319
AC:
1
AN:
31326
American (AMR)
AF:
0.0000568
AC:
2
AN:
35236
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24590
East Asian (EAS)
AF:
0.0000906
AC:
3
AN:
33126
South Asian (SAS)
AF:
0.000101
AC:
8
AN:
79008
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
44978
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5172
European-Non Finnish (NFE)
AF:
0.0000428
AC:
46
AN:
1075148
Other (OTH)
AF:
0.00
AC:
0
AN:
57250
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000265
AC:
4
AN:
150662
Hom.:
0
Cov.:
33
AF XY:
0.0000543
AC XY:
4
AN XY:
73650
show subpopulations
African (AFR)
AF:
0.0000485
AC:
2
AN:
41266
American (AMR)
AF:
0.00
AC:
0
AN:
15160
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3454
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4702
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4638
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10362
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000295
AC:
2
AN:
67776
Other (OTH)
AF:
0.00
AC:
0
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.558
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000264
ExAC
AF:
0.0000410
AC:
4

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
Long QT syndrome (2)
-
1
-
Cardiac arrhythmia (1)
-
1
-
Cardiovascular phenotype (1)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
CardioboostArm
Benign
0.00066
BayesDel_addAF
Uncertain
0.11
D
BayesDel_noAF
Uncertain
0.11
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.37
T
Eigen
Benign
0.077
Eigen_PC
Benign
0.11
FATHMM_MKL
Benign
0.75
D
LIST_S2
Uncertain
0.91
D
M_CAP
Pathogenic
0.61
D
MetaRNN
Benign
0.37
T
MetaSVM
Uncertain
0.71
D
MutationAssessor
Benign
1.5
L
PhyloP100
0.74
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-0.73
N
REVEL
Uncertain
0.57
Sift
Benign
0.28
T
Sift4G
Benign
0.23
T
Polyphen
0.95
P
Vest4
0.40
MutPred
0.18
Loss of MoRF binding (P = 0.0588)
MVP
0.93
MPC
0.67
ClinPred
0.10
T
GERP RS
5.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.9
Varity_R
0.14
gMVP
0.54
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs761933920; hg19: chr7-150644464; COSMIC: COSV100058955; COSMIC: COSV100058955; API